Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
68,333,029
-
Share change
-
+10,091,437
-
Total reported value
-
$907,454,217
-
Put/Call ratio
-
78%
-
Price per share
-
$13.28
-
Number of holders
-
139
-
Value change
-
+$143,542,378
-
Number of buys
-
70
-
Number of sells
-
49
Institutional Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q1 2019
As of 31 Mar 2019,
CYMABAY THERAPEUTICS INC - COM (CBAY) was held by
139 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
68,333,029 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, BlackRock Inc., PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, EAGLE ASSET MANAGEMENT INC, Redmile Group, LLC, CITADEL ADVISORS LLC, Foresite Capital Management IV, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., and CARILLON TOWER ADVISERS, INC..
This page lists
139
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.